Gabriel Aleixo, Lee P. Hartner, Mark Diamond, Lazlo Nziga, Daniel S. Lefler. "Liposomal vs conventional doxorubicin as first-line therapy in advanced soft tissue sarcomas: A tertiary US center’s 8.5-year experience.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e23533